This study by Nakashima and colleagues reveals that systemic miR-26a deficiency reduces pulmonary fibrosis by upregulating PTEN, thereby suppressing TIMP-1 in the PI3K/Akt-mTOR pathway. The gene discussed is MTOR; the disease is pulmonary fibrosis.